Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 2Phase 2 2

Status

Recruiting 3Not yet recruiting 2Active not recruiting 2

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Genitourinary 3Endocrine 1Breast 1

Conditions

Breast Neoplasms 987Neoplasms 796Carcinoma, Non-Small-Cell Lung 763Prostatic Neoplasms 588Colorectal Neoplasms 484Lung Neoplasms 468Neoplasm Metastasis 413Multiple Myeloma 382Leukemia, Myeloid, Acute 377Ovarian Neoplasms 316Pancreatic Neoplasms 297Melanoma 278Squamous Cell Carcinoma of Head and Neck 258Recurrence 244Carcinoma, Hepatocellular 240Brain Neoplasms 226Glioblastoma 217Triple Negative Breast Neoplasms 204Carcinoma, Renal Cell 200Head and Neck Neoplasms 198Lymphoma 193Stomach Neoplasms 190Precursor Cell Lymphoblastic Leukemia-Lymphoma 189Sarcoma 172Glioma 171Uterine Cervical Neoplasms 169Lymphoma, Non-Hodgkin 169Endometrial Neoplasms 169Lymphoma, Large B-Cell, Diffuse 166Urinary Bladder Neoplasms 160

Interventions

fezolinetant 1Tamoxifen 1Solifenacin Succinate 1Clonidine 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × Hot Flashes × 90 days × Clear all
NCT07594002 2026-05-27

Comparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy

University of Kentucky

Phase NA Not yet recruiting
40 enrolled
Genitourinary

Prostatic Neoplasms, Hot Flashes

NCT07535541 2026-05-08

BioWEAR

University of Virginia

Phase NA Recruiting
18 enrolled
Genitourinary

Prostatic Neoplasms, Hot Flashes

NCT05587296 2026-05-06

OASIS-4

Bayer

Phase 3 Active not recruiting
474 enrolled 14 charts

Hot Flashes

NCT06440967 2026-04-06

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

Astellas Pharma Inc

Phase 3 Active not recruiting
984 enrolled

Hot Flashes

NCT07294339 2026-03-19

ACU-HRBC-HF

Peking University People's Hospital

Phase NA Not yet recruiting
60 enrolled

Hot Flashes

NCT06957691 2026-03-09

Fezo-ADT

Brigham and Women's Hospital

Phase 2 Recruiting
60 enrolled
EndocrineGenitourinary

Adenocarcinoma, Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT01530373 2026-03-05

Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

University of Arkansas

Phase 2 Recruiting
110 enrolled
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡